Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Bone Therapeutics Provides Third Quarter 2021 Business Update

  • Read more about Bone Therapeutics Provides Third Quarter 2021 Business Update

Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

  • Read more about Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement

  • Read more about Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement

Bone Therapeutics announces closing of private placement

  • Read more about Bone Therapeutics announces closing of private placement

Bone Therapeutics: Information on the total number of voting rights and shares

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares

Transparency notification received from Nyenburgh Holding NV

  • Read more about Transparency notification received from Nyenburgh Holding NV

Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA

  • Read more about Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA

Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook

  • Read more about Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook

Transparency notification received from Nyenburgh Holding NV

  • Read more about Transparency notification received from Nyenburgh Holding NV

Bone Therapeutics to strategically focus on lead cell therapy product ALLOB

  • Read more about Bone Therapeutics to strategically focus on lead cell therapy product ALLOB

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions